How to build an effective protein degrader

March 31, 2021

Working in PROTACs, you’re tasked with the most challenging targets — that aim to address intractable diseases such as cancer, Alzheimer's, or Parkinson's disease. Despite the impressive promise of PROTACs, you still have to overcome many hurdles in order to work with these difficult targets.

This guide highlights the four major stages of targeted protein degradation, the challenges at each step, and questions you should ask yourself to make sure your final product will result in a complete protein degradation.

Download this guide to learn:

  • What are the most common roadblocks at key stages in PROTAC development
  • What methods and technologies help you overcome these challenges
  • What outcomes you should expect at each stage
Previous Article
Targeted protein degradation promises to lead the way to effective drugs for challenging targets
Targeted protein degradation promises to lead the way to effective drugs for challenging targets

Up next
Optimize the structure of your next round of PROTAC compounds by analyzing ternary binding affinities using Monolith
Optimize the structure of your next round of PROTAC compounds by analyzing ternary binding affinities using Monolith

Ready to characterize your most challenging interactions?

Discover tools to measure binding affinity

Learn more